Contributions

  • Michael A. Morse (Editor) - Contributor
  • Timothy M. Clay (Editor) - Contributor
  • H. Kim Lyerly (Editor) - Contributor

Publication

2004-01-28 - Humana Press

Language

English

Word Count

152,000 words, Guess

Page Count

608 pages

Physical Format

Hardcover

Identifiers

and 2 more
  • Better World Books9781588292094
  • Open LibraryOL8828378M

Classifications

  • LCCRC271.I45 H36 2004
  • LCCRC254-282

Description

The book is laid out into four sections including a Basic Science Background, General Vaccine and Immunotherapy Strategies, Tumor Specific Vaccines Being Developed and closing with a final section on General Background of Clinical Trials and Immune Analysis. The first section provides an overview of antigen processing, tumor antigen discovery, T cell activation, and augmenting the antigen-specific immune response. Section two progresses into a discussion of the different vaccination strategies currently under development. The third section includes chapters that introduce the reader to clinical trials in various malignancies. The final section in the book includes chapters discussing important issues in clinical trial design, analysis, and the regulatory requirements for bringing candidate vaccines through clinical trials and into clinical practice and use.

First Sentence

Interest in activating the immune system to control tumors dates to more than 100 yr ago and is often attributed to William B. Coley who used the inflammatory response to bacterial products as a form of immunotherapy (1).

Subjects

Other Editions

  • Handbook of Cancer Vaccines (Cancer Drug Discovery and Development)HardcoverHumana Press2004-01-28

Reader Reviews

No reviews yet for this book.

Be the first to share your thoughts!